123I-MIBG cardiac uptake, smell identification and 123I-FP-CIT SPECT inthe differential diagnosis between vascular parkinsonism and Parkinson's disease

Parkinsonism and Related Disorders

Volumn 20, Issue 2, 2014, Pages 192-197

  Navarro Otano, J ^a,b   Gaig, C ^a,b   Muxi, A ^a   Lomena F ^a   Compta, Y ^a,b   Buongiorno, M T ^a,b   Marti M J ^a,b   Tolosa, E ^a,b   Valldeoriola, F ^a,b  

^a UNIVERSITY OF BARCELONA   (Spain)

^b INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

Author keywords

123I FP CIT SPECT; Cardiac 123I MIBG; Parkinson's disease; UPSIT; Vascular parkinsonism

Indexed keywords

(3 IODOBENZYL)GUANIDINE I 123; IOMETOPANE I 123; LEVODOPA; (3 IODOBENZYL)GUANIDINE; 2 CARBOMETHOXY 8 (3 FLUOROPROPYL) 3 (4 IODOPHENYL)TROPANE; 2-CARBOMETHOXY-8-(3-FLUOROPROPYL)-3-(4-IODOPHENYL)TROPANE; DIAGNOSTIC AGENT; RADIOPHARMACEUTICAL AGENT; TROPANE DERIVATIVE;

ADULT; AGED; ARTICLE; CARDIAC UPTAKE; CARDIOVASCULAR PARAMETERS; CLINICAL ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; DISEASE DURATION; DRUG EFFECT; DRUG RESPONSE; FEMALE; HEART TO MEDIASTINUM RATIO; HUMAN; INTERMETHOD COMPARISON; MALE; MEDICAL PARAMETERS; ODOR; ONSET AGE; PARKINSON DISEASE; PARKINSONISM; PRIORITY JOURNAL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; VASCULAR PARKINSONISM; (123)I-FP-CIT SPECT; CARDIAC (123)I-MIBG; HEART; PHYSIOLOGY; SCINTISCANNING; UPSIT;

(123)I-FP-CIT SPECT; CARDIAC (123)I-MIBG; PARKINSON'S DISEASE; UPSIT; VASCULAR PARKINSONISM;

3-IODOBENZYLGUANIDINE; AGED; CROSS-SECTIONAL STUDIES; DIAGNOSIS, DIFFERENTIAL; FEMALE; HEART; HUMANS; MALE; PARKINSON DISEASE; PARKINSON DISEASE, SECONDARY; RADIOPHARMACEUTICALS; SMELL; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TROPANES;

EID: 84893662679     PISSN: 13538020     EISSN: 18735126     Source Type: Journal    
DOI: 10.1016/j.parkreldis.2013.10.025     Document Type: Article

References (30)

1. Critchley M. Arteriosclerotic parkinsonism. Brain 1929, 52:23-83.
2. Jellinger K.A. Prevalence of cerebrovascular lesions in Parkinson's disease. A postmortem study. Acta Neuropathol 2003, 105:415-419.
3. Kalra S., Grosset D.G., Benamer H.T. Differentiating vascular parkinsonism from idiopathic Parkinson's disease: a systematic review. Mov Disord 2010, 25:149-156.
4. Winikates J., Jankovic J. Clinical correlates of vascular parkinsonism. Arch Neurol 1999, 56:98-102.
5. Zijlmans J.C., Daniel S.E., Hughes A.J., Revesz T., Lees A.J. Clinicopathological investigation of vascular parkinsonism, including clinical criteria for diagnosis. Mov Disord 2004, 19:630-640.
6. Hughes A.J., Daniel S.E., Kilford L., Lees A.J. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. JNeurol Neurosurg Psychiatr 1992, 55:181-184.
7. Murrow R.W., Schweiger G.D., Kepes J.J., Koller W.C. Parkinsonism due to a basalganglia lacunar state: clinicopathologic correlation. Neurology 1990, 40:897-900.
8. Kagi G., Bhatia K.P., Tolosa E. The role of DAT-SPECT in movement disorders. JNeurol Neurosurg Psychiatry 2010, 81:5-12.
9. 123I-FP-CIT SPECT imaging of dopamine transporters in patients with cerebrovascular disease and clinical diagnosis of vascular parkinsonism. JNucl Med 2004, 45:1688-1693.
10. Kline R.C., Swanson D.P., Wieland D.M., Thrall J.H., Gross M.D., Pitt B., et al. Myocardial imaging in man with I-123 meta-iodobenzylguanidine. JNucl Med 1981, 22:129-132.
11. Orimo S., Takahashi A., Uchihara T., Mori F., Kakita A., Wakabayashi K., et al. Degeneration of cardiac sympathetic nerve begins in the early disease process of Parkinson's disease. Brain Pathol 2007, 17:24-30.
12. Doty R.L., Shaman P., Dann M. Development of the University of Pennsylvania smell identification test: a standardized microencapsulated test of olfactory function. Physiol Behav 1984, 32:489-502.
13. Katzenschlager R., Lees A.J. Olfaction and Parkinson's syndromes: its role in differential diagnosis. Curr Opin Neurol 2004, 17:417-423.
14. 123I-MIBG cardiac uptake and smell identification in parkinsonian patients with LRRK2 mutations. JNeurol 2011, 258:1126-1132.
15. Tomlinson C.L., Stowe R., Patel S., Rick C., Gray R., Clarke C.E. Systematic review of levodopa dose equivalency reporting in Parkinson's disease. Mov Disord 2010, 25:2649-2653.
16. Muxi A., Paredes P., Navales I., Valldeoriola F., Gaig C., Lomena F., et al. Diagnostic cutoff points for (1)(2)(3)I-MIBG myocardial scintigraphy in a Caucasian population with Parkinson's disease. Eur J Nucl Med Mol Imaging 2011, 38:1139-1146.
17. 123I]-FP-CIT study group. Mov Disord 2000, 15:503-510.
18. Goldstein D.S., Sharabi Y., Karp B.I., Bentho O., Saleem A., Pacak K., et al. Cardiac sympathetic denervation preceding motor signs in Parkinson disease. Cleve Clin J Med 2009, 76(Suppl.2):S47-S50.
19. Goldstein D.S., Holmes C., Sewell L., Park M.Y., Sharabi Y. Sympathetic noradrenergic before striatal dopaminergic denervation: relevance to Braak staging of synucleinopathy. Clin Auton Res 2012, 22:57-61.
20. Navarro-Otano J., Gelpi E., Mestres C.A., Quintana E., Rauek S., Ribalta T., et al. Alpha-synuclein aggregates in epicardial fat tissue in living subjects without parkinsonism. Parkinsonism Relat Disord 2013, 19:27-31. discussion 27.
21. Orimo S., Suzuki M., Inaba A., Mizusawa H. (123)I-MIBG myocardial scintigraphy for differentiating Parkinson's disease from other neurodegenerative parkinsonism: a systematic review and meta-analysis. Parkinsonism Relat Disord 2012, 18:494-500.
22. 123I-MIBG cardiac scintigraphy for the diagnosis of Lewy body-related disorders. Mov Disord 2011, 26:1218-1224.
23. Katzenschlager R., Zijlmans J., Evans A., Watt H., Lees A.J. Olfactory function distinguishes vascular parkinsonism from Parkinson's disease. JNeurol Neurosurg Psychiatry 2004, 75:1749-1752.
24. Antonini A., Vitale C., Barone P., Cilia R., Righini A., Bonuccelli U., et al. The relationship between cerebral vascular disease and parkinsonism: the VADO study. Parkinsonism Relat Disord 2012, 18:775-780.
25. 123I-FP-CIT SPECT imaging invascular parkinsonism and Parkinson's disease. JNeurol Neurosurg Psychiatry 2013, 84:122-129.
26. Contrafatto D., Mostile G., Nicoletti A., Dibilio V., Raciti L., Lanzafame S., et al. [(123) I]FP-CIT-SPECT asymmetry index to differentiate Parkinson's disease from vascular parkinsonism. Acta Neurol Scand 2012, 126:12-16.
27. Thompson P.D., Marsden C.D. Gait disorder of subcortical arteriosclerotic encephalopathy: Binswanger's disease. Mov Disord 1987, 2:1-8.
28. Baezner H., Blahak C., Poggesi A., Pantoni L., Inzitari D., Chabriat H., et al. Association of gait and balance disorders with age-related white matter changes: the LADIS study. Neurology 2008, 70:935-942.
29. Wang H.C., Hsu J.L., Leemans A. Diffusion tensor imaging of vascular parkinsonism: Structural changes in cerebral white matter and the association with clinical severity. Arch Neurol 2012, 1-9.
30. 123I-MIBG imaging have a role to play in early diagnosis?. JNucl Med Technol 2004, 32:66-71.